One of the key takeaways from the meeting, and from phase I of CHL UK, was that we tested and learned together for a whole year, but it’s now time to put our energy into what works.
Investing in promising new pharmaceutical platforms like oligonucleotide therapies could reduce the gap between first detection and total eradication in future pandemics.
In Episode 5, host Lisa Ling speaks with nurse Nicole Lincoln MS, RN, FNP-BC, CCNS who’s on the frontlines in the ICU fighting COVID-19 and nursing innovator, Rebecca Love RN, BS, MSN, FIEL, who’s leading the charge to advocate for her profession.
I hope that everyone is staying safe and healthy as we strive to adapt to these challenging circumstances. The COVID-19 pandemic is placing a heavy burden on all of us in many ways -- including our mental health.
She has spent her career investigating some of the world's most pervasive infectious diseases—HIV and Ebola, just to name a couple—and now Hanneke Schuitemaker, Ph.D., is fighting a virus that could very well define her career.
On #GivingTuesdayNow, we’re proud to recognize and support the heroic efforts of organizations, essential workers and others who are putting in countless hours to care for and provide relief to communities impacted by the COVID-19 pandemic.
Dr. Kuffner’s inspiring act was made possible as part of the J&J COVID-19 Medical Personnel Leave Policy, which allows employees to donate their time and expertise on the frontlines.
People are everything. As leaders, we need to assess our teams, empower those who are willing and able to help in a crisis, and look after those who need support.
This week in Episode 3, Lisa Ling interviews National Academies member and University of Connecticut professor Cato Laurencin, M.D., Ph.D., to learn what his new coronavirus study reveals. Plus, what’s needed to mass-produce a vaccine.
This week, Lisa Ling speaks with three leading scientists who have been on the frontlines of Zika, malaria and HIV to give you the inside scoop on the latest in the development of a coronavirus vaccine, and the process of going from lab to clinic.
Antea Group's health and safety consultants understand what it takes to help make a positive impact on safety culture. Read blogs, insights, and more...
